Loading the company…
Loading the company…
Families: Debridement & negative-pressure wound therapy.
All companies · Product and company coverage
In the last ten years FDA made 3 decisions for Carilex Medical (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2018 (2). The latest was on 2024-04-17.
| Family | Decisions on record |
|---|---|
| Debridement & negative-pressure wound therapy | 4 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2024-04-17 | 510(k) | K231646 | Carilex VT¿200-i NX |
| 2018-08-09 | 510(k) | K173407 | VT - 100, VT - 200 |
| 2018-06-08 | 510(k) | K172725 | VT Dressing Kits |
| 2016-10-13 | 510(k) | K161410 | VT·One, VT·One 60days |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Carilex Medical.